Cite
HARVARD Citation
Aróstegui, J. et al. (2015). Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study. Pediatric rheumatology online journal. 13 (1), p. 1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aróstegui, J. et al. (2015). Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study. Pediatric rheumatology online journal. 13 (1), p. 1. [Online].